ZNF442 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.071600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.417000E-01
Normal-vs-Stage2
3.059800E-01
Normal-vs-Stage3
1.376590E-01
Normal-vs-Stage4
3.072400E-01
Stage1-vs-Stage2
3.975200E-01
Stage1-vs-Stage3
2.912200E-01
Stage1-vs-Stage4
9.289800E-01
Stage2-vs-Stage3
4.059600E-01
Stage2-vs-Stage4
4.148000E-01
Stage3-vs-Stage4
2.300000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.087400E-01
Normal-vs-AfricanAmerican
2.240800E-01
Normal-vs-Asian
1.306580E-01
Caucasian-vs-AfricanAmerican
6.583400E-01
Caucasian-vs-Asian
6.516000E-01
AfricanAmerican-vs-Asian
6.117000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.133200E-01
Normal-vs-Female
3.009200E-01
Male-vs-Female
6.978800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.675000E-01
Normal-vs-Age(41-60Yrs)
4.566500E-02
Normal-vs-Age(61-80Yrs)
2.892600E-01
Normal-vs-Age(81-100Yrs)
2.193600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.186800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.554500E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.257140E-03
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.203700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.962840E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.190360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.277600E-02
Normal-vs-Daily Drinker
1.217930E-02
Normal-vs-Weekly Drinker
2.887700E-02
Normal-vs-Occasional Drinker
2.698600E-01
Normal-vs-Social Drinker
5.878200E-02
Non Drinker-vs-Daily Drinker
3.280400E-01
Non Drinker-vs-Weekly Drinker
6.178000E-01
Non Drinker-vs-Occasional Drinker
4.524200E-01
Non Drinker-vs-Social Drinker
8.796600E-01
Daily Drinker-vs-Weekly Drinker
7.007200E-01
Daily Drinker-vs-Occasional Drinker
6.649600E-01
Daily Drinker-vs-Social Drinker
2.761200E-01
Weekly Drinker-vs-Occasional Drinker
9.504800E-01
Weekly Drinker-vs-Social Drinker
5.095000E-01
Occasional Drinker-vs-Social Drinker
3.685200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.444800E-01
Normal-vs-Grade 2
1.809970E-01
Normal-vs-Grade 3
1.412640E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.038600E-01
Grade 1-vs-Grade 3
4.551800E-01
Grade 1-vs-Grade 4
2.444800E-01
Grade 2-vs-Grade 3
7.778000E-01
Grade 2-vs-Grade 4
1.809970E-01
Grade 3-vs-Grade 4
1.412640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.922400E-01
Normal-vs-NonDiabetic
2.949000E-01
Diabetic-vs-NonDiabetic
9.237200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.620200E-01
Normal-vs-NoPancreatitis
2.952800E-01
Pancreatitis-vs-NoPancreatitis
4.746000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.959000E-01
Normal-vs-N1
3.142400E-01
N0-vs-N1
5.929200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.388600E-01
Normal-vs-TP53-NonMutant
4.406600E-01
TP53-Mutant-vs-TP53-NonMutant
8.094300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
